Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Vizgen provides spatial multi-omics platforms enabling researchers to reveal cellular insights through spatial transcriptomics proteomics.
Elephas harnesses latest advances in cancer biology, multimodal microscopy, and artificial intelligence to empower clinical decision-making.
Outcomes4Me develops direct-to-patient AI-driven platform designed to assist cancer patients in managing their care.
QbDVision is a biopharma company that offers a platform designed specifically for biotech products, teams, and processes.
EnPlusOne Biosciences provides innovative solutions for emerging RNA therapeutics.
Transition Bio provides condensate technology for drug discovery and diagnostics.
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing.
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.
Totus Medicines employs uses AI/ML and innovative DNA-encoded covalent library tech to discover small molecule medicines.
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Scitara offers a cloud-based connectivity platform that transforms integration between instruments and lab informatics applications.
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.
Faro Health is a company that handles the tedious work better left for a computer.
Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics.
Isolere Bio is a Healthcare Company provides manufacturing solutions,facilitate therapeutic developments.
Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies.
Triumvira Immunologics is an immunotherapy company that develops novel T cell therapies for cancer.
Nanoview Biosciences is developing proprietary products that support research, translation and delivery of precision medicine.
Walking Fish Therapeutics is developing a platform to harness B cells’ capability to activate the immune system.
SimBioSys is developing a Computational Microscope to provide new insight into the behavior of cancers.
Hawthorne Effect is a visit management system connecting sponsors, investigators & patients to make clinical trials accessible & convenient.
ArtisanBio is provider of cell engineering and data analysis solutions that advance the cell therapy revolution.
Northpond Ventures has invested in 49 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Northpond Ventures's top investment sectors include Biotechnology, Health Care, Medical, Life Science, Therapeutics. The firm invests across 20 different industry categories.
Among tracked funding rounds, Code Biotherapeutics received $75.0M in a Series A round. Northpond Ventures's total known invested capital is $1.0B.
Northpond Ventures's average investment size is $24.9M across its portfolio of 49 companies.
Recent Northpond Ventures portfolio additions include Vizgen, Elephas, Outcomes4Me, QbDVision, EnPlusOne Biosciences. These companies were founded in 2020 or later.